We are a French company dedicated to analysing health big data and developing innovative tools

Our Approach

Our Approach

We
analyze
health big data
economics data
In France
In Europe
In the USA
For
Health
companies
Hospitals
Trade unions
and Authorities
data analyses
methodologies
Statistics
Data Mining
Process Mining
provide
answers
marketing
and sales issues
epidemiological
regulatory
medico-economic
share the results
of the studies
Html5 websites
native iOS Apps

Unrivalled analyses with French health big data

HEVA was the one of the first companies to have a full access to the French database of inpatients (PMSI: Programme de Médicalisation des Systèmes d'Information) in accordance to the French data privacy committee.
We are able to root out the relevant information for epidemio-economic analyses, marketing studies in order to give a new vision for health industries, hospitals and authorities (Patient pathways, trajectories care…)

Since 2005 and the coming of the French DRG prospective payment, this comprehensive database has still enhanced its data, so as to precisely describe the activity of French hospitals with data like diagnosis, surgical procedures, expensive drugs administered, medical devices used, real cost to manage patients, ...

In order to always offer innovative solutions, HEVA has constantly improved its methodology and process to re-invent the using of the health data: following patients during several years, valuation of hospital cost, analyze of compliance of SPC for expensive drugs, performing digital and dynamic maps for trajectories cares and patients pathway, fulfilling of iPad and web solutions.

These new creative and ingenious tools of data visualization enable Health actors to propose groundbreaking solutions for the new actors like regional authorities to work on care cooperation, health care provision, optimization of care regional projects...

Anticipating the controlled liberalization of the data, HEVA already lead up deeper analyses, alone or with its partners.

Employees

Employees

Founded in September 2005 by Ludovic Lamarsalle and Alexandre Vainchtock, both Pharmacist (Pharm.D) and Health economist (Msc).

Employees
26
Health big data
17
1
COO
1
Health Data expert
3
Data Scientists
3
Consultants
5
Data Management
4
Methods and statistics
Executive Assistant
1
Datavisualization Digital
8
3
web / iOS Designer
2
iOS CODERS
3
web developers

Our Data

Our Data
per Year

Stays
317M
Patients
67M
Coding lines
10M
Coffees
20 000
Projects
200

Clients

Clients

ABBVIE ACCURAY AEC PARTNER ALLERGAN AMGEN ANALYSIS GROUP ARS PACA ASEPT INMED ASTELLAS ASTRAZENECA AXELION PHARMA BAXTER BECTON DICKINSON BOEHRINGER INGELHEIM BOSTON SCIENTIFIC BRISTOL-MYERS SQUIBB CELGENE CNAMTS CONCEPTUS COOK CSL BEHRING CYBERONICS DAIICHI SANKYO DEVICOR MEDICAL EHESP EISAI ETHICON FABRE FHF GILEAD GSK HCL HOLOGIC HRA PHARMA IPSEN JANSSEN LEO PHARMA LFB LILLY LUNDBECK MEDPASS MEDTRONIC MERCK SERONO MSD NESTLÉ HEALTH SCIENCE NOVARTIS PFIZER PIERRE FABRE ROCHE SANOFI SANOFI PASTEUR MSD SERVIER SHIRE SIGVARIS SJM SMITH&NEPHEW SNITEM SORIN STARGEN TAKEDA TESSELON ZIMMER

Publications

Publications

HEVA contributes to the development of research through publications (Scientific congress, peer reviews…) and its partnership with the French academies. These information, data algorithms and studies allow to beef up our community of Health data.

Publications

Extra-cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis
Lucie DE LEOTOING / Charlène TOURNIER / Alexandre VAINCHTOCK
ESMO Open - 2018

Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study
de Léotoing L / Lamarsalle L
Europace - 2018

COSTS ASSOCIATED WITH HOSPITALISATION IN HIV-POSITIVE PATIENTS IN FRANCE
Lucie DE LÉOTOING / Gwendoline CHAIZE / Alexandre VAINCHTOCK
AIDS - 2018

French hospital discharge database (PMSI) and bacterial resistance: Is coding adapted to hospital epidemiology?
de Léotoing L / Chaize G, Vainchtock A
Med Mal Infect - 2018

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
Cécile Blein / Charlène Tournier / Alexandre Vainchtock
Cancer Medecine - 2018

Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective
Soline Leblanc / Cécile Blein
Infection Control Hospital Epidemiology - 2017

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)
Cécile Blein / Soline Leblanc / Alexandre Vainchtock
PLOS One - 2017

Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)
Camille AMAZ / Lucie DE LÉOTOING / Alexandre VAINCHTOCK
BMC Health Services Research - 2017

Optimal Process Mining for Large and Complex Event Logs
Martin Prodel / Baptiste Jouaneton / Ludovic Lamarsalle
IEEE TASE (journal) - 2017

Disparités régionales des hospitalisations pour complication de l’hépatite chronique C en 2012
Lucie de Léotoing / Alexandre Vainchtock
Santé publique - 2017

Stochastic Simulation of Clinical Pathways from Raw Health Databases
Martin Prodel / Vincent Augusto / Xiaolan Xie / Baptiste Jouaneton / Ludovic Lamarsalle
CASE - 2017

Evaluation of discovered clinical pathways using process mining and joint agent-based discrete-event simulation
Martin Prodel / Baptiste Jouaneton / Ludovic Lamarsalle
Winter Simulation Conference proceedings - 2016

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home
Ludovic Lamarsalle
Support Care Cancer - 2016

Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study
Gwendoline Chaize / Alexandre Vainchtock
International Journal of Cardiology - 2016

Vers un diagnostic territorial à partager
Remerciements HEVA
Gestion hospitalières - 2016

Hospitalisations pour neutropénie fébrile chimio-induite en France en 2010/2011 : impact clinique et caractéristiques des patients à partir des données de la base PMSI
Alexandre Vainchtock
Bulletin du Cancer - 2016

Chronic hepatitis C: Burden of disease andcost associated with hospitalisations inFrance in 2012 (The HEPC-LONE study)
Lucie de Léotoing / Alexandre Vainchtock
Clinics and Research in Hepatology and Gastroenterology - 2015

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalizd in France
Gwendoline Chaize / Alexandre Vainchtock
Europace - 2015

Discovery of patient pathways from a national hospital database using process mining and integer linear programming
Martin Prodel / Baptiste Jouaneton / Ludovic Lamarsalle
IEEE Int CASE - 2015

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
Cécile Blein /Alexandre Vainchtock
BMC infectious disease - 2015

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalizd in France
Gwendoline Chaize / Alexandre Vainchtock
Europace - 2015

Management of immune thrombocytopenia in adults
Remerciements HEVA
BHJ - 2015

Costs of dengue in th three French territories of the Americas: an analysis of the hospital medical information system ( PMSI) database
Cécile Blein
European Journal of Health economics - 2015

The Cost of Thromboembolic Events in Hospitalized Patients with Breast or Prostate Cancer in France
Alexandre Vainchtock
Advanced in Therapy - 2015

Activity and cost related to hospital management of zona in france: focus on the zona ophthalmic
Alexandre Vainchtock
Geriatr Psychol Neuropsychiatr Vieil - 2014

Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006–2010
Cécile Blein / Ludovic Lamarsalle
Eur J Obstet Gynecol Reprod Biol - 2014

Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Gwendoline Chaize / Alexandre Vainchtock
J Stroke Cerebrovasc Dis - 2014

Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France.
Ludovic Lamarsalle
Epidemiol Infect - 2013

How did chronic hepatitis C impact costs related to hospital health care in France in 2009?
Alexandre Vainchtock / Baptiste Jouaneton
Clin Res Hepatol Gastroenterol - 2013

Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
Alexandre Vainchtock / Baptiste Jouaneton
Clin Exp Rheumatol - 2012

Burden of breast cancer with brain metastasis: a French national hospital database analysis.
Alexandre Vainchtock
J Med Econ - 2012

Surveillance de la prise en charge de l’hépatite chronique C : analyse des données nationales du Programme de médicalisation des systèmes d’information (PMSI)
Alexandre Vainchtock / Baptiste Jouaneton
BEH - 2012

Economic burden of HPV-related cancers in France
Remerciements HEVA
Vaccine - 2010

Economic burden of anal cancer management in France.
Alexandre Vainchtock
Rev Epidemiol Sante Publique - 2010

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
Alexandre Vainchtock
Head Neck Oncol - 2010

Coût de prise en charge des cancers de la vulve et du vagin en France
Alexandre Vainchtock
Journal d’Économie Médicale - 2010

Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
Alexandre Vainchtock
Eur J Obstet Gynecol Reprod Biol - 2009

L'utilisation de la base nationale PMSI pour déterminer le coût d'un symptôme : le cas de la neutropénie fébrile
Alexandre Vainchtock
Journal d’Économie Médicale - 2007

Papers

Aggressiveness of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey
Charlène Tournier / Cécile Blein
WCLC - 2018

Une nouvelle méthodologie d’analyse pour trouver des profils de coûts atypiques au sein des patients vivants avec le VIH et à partir des données Sniiram
M. Prodel / C. Tournier / L. de Léotoing
AFCRO DSVR - 2018

Diagnostic de cancer du poumon à un stade avancé : déterminants socioéconomiques et accès aux soins primaires et secondaires (étude TERRITOIRE)
C. Blein
Colloque "Santé : équité ou égalité? Définir, mesurer, agir - 2018

Diversité des parcours de soins des patients atteints de cancer du poumon entre 4 régions françaises : définition de mesures de dissimilarité
MARTIN PRODEL / CECILE BLEIN
ADELF EMOIS - 2018

A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer in day sessions
C.BLEIN / M.PRODEL
2nd World Congress on Health Economics Policy & Outcomes Research - 2017

Evaluation multicentrique via des données en vie réelle du temps de parcours des patientes prises en charge pour leur cancer du sein au sein d’une hospitalisation de jour en fonction du mode d’administration de trastuzumab (IV versus SC)
BLEIN Cécile / PRODEL Martin
10èmes journées du Grand Sud en Information Médicale - 2017

Analyses de sensibilité des comorbidités sur le parcours de soin des patients implantés d’un défibrillateur cardiaque à partir des données PMSI
Martin Prodel, Ludovic Lamarsalle, Alexandre Vainchtock
9ème Colloque Données de Santé en vie réelle - 2017

Socioeconomic Determinants of Late Diagnosis of Lung Cancer in France:
C. Blein / S. Leblanc
CPLF - 2017

Burden of Clostridium difficile infections in France in 2014
Thibaut Galvain, Soline leblanc et Cécile BLEIN
RICAI - 2016

Diversité des parcours de soins des patients atteints de cancer du poumon entre régions françaises
C. Blein / A. Vainchtock8
ENCC - 2016

THE NATIONAL BURDEN IN FRANCE OF HOSPITAL CARE FOR PATIENTS WITH HEPATIC ENCEPHALOPATHY: DATA FROM THE FRENCH NATIONAL HOSPITAL DATABASE (PMSI)
Cecile Blein / Camille Amaz
UEG Week - 2016

Disparities in lung cancer incidence and management care in France: a nationwide cohort study
Cécile Blein /Alexandre Vainchtock/benoit saitta
WCLC - 2015

Access to innovative drugs in patients with metastatic lung cancer in French public hospitals (the TERRITOIRE study)
Cecile BLEIN Benoit SAITTA Alexandre Vainchtock
ISPOR 2015 - 2015

Entre honoraires et revenus : les charges » - l'offre médicale par spécialité d'exercice
Cécile BLEIN/Baptiste JOUANETON
Colloque SENAT LE BLOC, Dépassements d’honoraires et tarifs opposables » : analyse et propositions - 2012

Retrospective study on five DRG follow-up in French casemix 2009 analysis for the determination of quality indicators in P4O reforms

Congrès Patient Classification Sytems - 2012

Evaluation des taux de regrets au sein de la population de femmes stérilisées : Utilisation des bases PMSI MCO de 2006 à 2010
Ludovic LAMARSALLE
Université des Pharmaco-Epidémiologiques - 2011

Posters

Costs of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey
Charlène Tournier, Cécile Blein
WCLC - 2018

Extra-cost of brain metastases in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis
Lucie de Léotoing, Charlène Tournier, Alexandre Vainchtock
ESMO - 2018

CARE PATHWAY DIVERSITY OF PATIENTS WITH MULTIPLE SCLEROSIS BETWEEN FRENCH REGIONS
C. Blein
ISPOR - 2018

A MULTICENTRIC EVALUATION OF CONSUMABLES AND TRANSPORTS COST OF BREAST CANCER PATIENT’S TREATED BY TRASTUZUMAB ACCORDING TO THE ADMINISTRATION FORM (IV VERSUS SC)
C.Blein
ISPOR - 2018

DIVERSITY OF PATIENTS PATHWAYS WITH LUNG CANCER BETWEEN 4 FRENCH REGIONS: DEFINITION OF DISSIMILARITY MEASURES
Prodel M, Blein C
ISPOR - 2018

Direct cost of allogeneic hematopoietic stem cell transplantation (ahsct) for relapsed/refractory (rr) diffuse large b-cell lymphoma patients from the french hospital perspective
Lafon T, Blein C
ISPOR - 2018

DIRECT COST STUDY OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) FOR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM THE FRENCH HOSPITAL PERSPECTIVE
Lafon T, Blein C
ISPOR - 2018

Economic burden of end-of-life aggression in lung cancer patients from the french health insurer perspective
Cécile Blein, Charlène Tournier
ISPOR - 2018

Extra-cost of brain metastases in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis
Lucie de Léotoing, Charlène Tournier, Alexandre Vainchtock
ISPOR - 2018

Nivolumab dans le traitement du cancer du poumon métastatique en France : analyse des 10 621 patients traités en 2015 et 2016 à partir des données du PMSI
B. Jouaneton, A. Vainchtock
22ème Congrès de pneumologie de langue Française - 2018

Utilisation de nivolumab dans le traitement du cancer du poumon avancé ou métastatique en France pendant les périodes d’ATU et post-ATU : suivi à partir des données hospitalières du PMSI
B. Jouaneton, A. Vainchtock
10ème Colloque Données de santé en vie réelle - 2018

Estimation de la prévalence et incidence du mésothéliome pleural malin (PMSI-MCO 2016)
Charlène Tournier, Lucie de Léotoing
10ème Colloque Données de santé en vie réelle - 2018

COMPARAISON DES COÛTS DU TRAITEMENT DES ANÉVRISMES DE L’ARTÈRE POPLITÉE PAR ENDOPROTHÈSE VASCULAIRE DÉDIÉE ou PAR PONTAGE PROTHETIQUE
de Léotoing L, Leblanc S, Vainchtock A.
10ème Colloque Données de santé en vie réelle - 2018

Patients atteints de cancer du poumon : Analyse des caractéristiques des décès hospitaliers entre 2010/2011 et 2015/2016 à partir des bases PMSI-MCO – France
Charlène Tournier, Cécile Blein
10ème Colloque Données de santé en vie réelle - 2018

Peut-on évaluer l’épidémiologie hospitalière des infections bactériennes via le PMSI ?
Lucie de Léotoing, Gwendoline Chaize
ADELF-EMOIS - 2018

SCHIZOPHRÉNIE : ÉTUDE DES DISPARITÉS RÉGIONALES ÉPIDÉMIOLOGIQUES ET ÉCONOMIQUES (PMSI 2015)
G. CHAIZE, H. PITARD, V. LEPROU, L. LAMARSALLE
CFP - 2017

BUDGET IMPACT OF POST-STROKE DYSPHAGIA: DATABASE ANALYSES OF HOSPITAL DISCHARGES IN FRANCE AND SWITZERLAND
Benoit Saitta, Baptiste Jouaneton, Lucie de Léotoing
ISPOR - 2017

ECONOMIC BURDEN OF HOSPITALIZATIONS RELATED TO PULMONARY ARTERIAL HYPERTENSION (PAH) in France
de Léotoing L., Tournier C., Vainchtock A.
ISPOR - 2017

IS IT POSSIBLE TO ACCURATELY IDENTIFY RARE DISEASES USING NATIONAL HOSPITAL DISCHARGE DATABASES?
de Léotoing L., Tournier C., Vainchtock A.
ISPOR - 2017

Burden of hospitalizations related to spinal tumors in France - 2012 VS 2014
de Léotoing L, Tournier C, Jouaneton B, Vainchtock A
ISPOR - 2017

Burden of hospitalizations related to spinal tumors in France - 2012 VS 2014
de Léotoing L, Tournier C, Jouaneton B, Vainchtock A
Eurospine - 2017

HOSPITAL BURDEN ≥ 18 MONTHS AFTER SURGICAL TREATMENT OF FUNCTIONAL MENORRHAGIA IN FRANCE
de Léotoing L., Chaize G., Lafon T., Lamarsalle L.
ISPOR - 2017

COST EFFECTIVENESS ANALYSIS OF FOUR SURGICAL STRATEGIES FOR THE TREATMENT OF FUNCTIONAL MENORRHAGIA IN France
de Léotoing L., Chaize G., Lafon T., Lamarsalle L.
ISPOR - 2017

COMPARAISON DES COÛTS DU TRAITEMENT DES ANÉVRISMES DE L’ARTÈRE POPLITÉE PAR ENDOPROTHÈSE VASCULAIRE DÉDIÉE ou PAR PONTAGE PROTHETIQUE
de Léotoing L, Leblanc S, Vainchtock A.
Europharmat - 2017

HOSPITAL COSTS ASSOCIATED WITH DEDICATED VASCULAR ENDOPROSTHESIS vs PROSTHETIC BYPASS IN POPLITEAL ARTERY ANEURYSM TREATMENT
de Léotoing L, Leblanc S, Vainchtock A.
ISPOR - 2017

Nivolumab dans le traitement du cancer du poumon métastatique en France : analyse des 10 621 patients traités en 2015 et 2016 à partir des données du PMSI
B. Jouaneton , A. Vainchtock
22e CPLF - 2017

EUROPEAN COMPARISON OF SPINAL SURGERY HOSPITALIZATIONS FROM 2010 TO 2013 ACCORDING TO PATIENT PROFILES
Lucie de Léotoing, Cécile Blein, Alexandre Vainchtock
Eurospine - 2017

COST STUDY OF IMMUNE THROMBOCYTOPENIA (ITP) MANAGEMENT FROM THE FRENCH HOSPITAL PERSPECTIVE
T LAFON, C BLEIN
ISPOR - 2017

BUDGET IMPACT OF POST-STROKE DYSPHAGIA: DATABASE ANALYSES OF HOSPITAL DISCHARGES IN FRANCE AND SWITZERLAND
Benoit Saitta, Baptiste Jouaneton, Lucie de Léotoing
ESOC - 2017

European comparison of spinal surgery hospitalizations from 2010 to 2013 according to patient profiles
C. Blein, L. De Leotoing, C. Amaz, C. Tournier, A.Vainchtock
Informatics for Health - 2017

Prediction of costs associated with the hospital management of HIV patients in France
Martin PRODEL, Camille AMAZ, Alexandre VAINCHTOCK
JESS - 2017

Fardeau des comorbidités chez les patients VIH hospitalisés en France : analyse des données françaises PMSI
L. de Léotoing, G. Chaize, A. Vainchtock
SFLS - 2016

Utilisation des données françaises du PMSI pour évaluer le fardeau économique des hospitalisations liées au VIH
L. de Léotoing, G. Chaize, A. Vainchtock
SFLS - 2016

Prediction of costs associated with the hospital management of hiv patients in france using an advanced data mining approach on the french medical information system database
Martin PRODEL, Camille AMAZ, Alexandre VAINCHTOCK
ISPOR - 2016

WHAT IS THE HOSPITAL ECONOMIC BURDEN OF HIV IN FRANCE? RESULTS FROM AN ANALYSIS OF THE NATIONAL FRENCH MEDICAL INFORMATION SYSTEM DATABASE
L de Léotoing, G Chaize, A Vainchtock
ISPOR - 2016

Burden of Comorbidities in Hospitalized HIV Patients in France: National French Medical Information System Database, 2014
L de Léotoing, G Chaize, A Vainchtock
International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV - 2016

France-Spain Comparison of hospital delivery mode between 2006 and 2014 according comorbidity profiles of patients
B. Saitta, C. Blein, A.VAINCHTOCK,
PCSI - 2016

ECONOMIC BURDEN OF MEDICAL TRANSPORTS IN FRANCE OVER THE YEAR 2014
C. Feyt, C. Blein, A.Vainchtock
ISPOR - 2016

EUROPEAN COMPARISON OF SPINAL SURGERY HOSPITALIZATIONS FROM 2010 TO 2013 ACCORDING TO PATIENT PROFILES
C. Blein, L. De Leotoing, C. Amaz C. Tournier,A.Vainchtock
ISPOR - 2016

FRANCE-SPAIN COMPARISON OF HOSPITAL DELIVERY MODE BETWEEN 2006 AND 2014 ACCORDING COMORBIDITY PROFILES OF PATIENTS
B. Saitta, C. Blein, A.VAINCHTOCK
ISPOR - 2016

BURDEN OF DISEASE AND MANAGEMENT OF MESOTHELIOMA IN FRANCE: A NATIONAL COHORT ANALYSIS
Tournier C, Blein C, Vainchtock A
ISPOR - 2016

ECONOMIC BURDEN OF HOSPITALIZATION FOR HEPATIC ENCEPHALOPATHY IN FRANCE: AN ANALYSIS OF COST DISCRIMINATING FACTORS BY PATIENT PROFILE
C. Amaz / C. Blein
ISPOR - 2016

Utilisation des données de l’OpenDAMIR pour l’exploration des remboursements de l’Assurance Maladie : application aux transports sanitaires
Cécile BLEIN/ Clément FEYT
Journée du grand sud - 2016

Utilisation des données françaises du PMSI pour évaluer l'impact en santé publique des hospitalisations pour EH
cécile BLEIN/ Camlle AMAZ
Journée du grand sud - 2016

Le fardeau des hospitalisations pour l’encéphalopathie hépatique en France : étude des données françaises du PMSI
cécile BLEIN/ Camlle AMAZ
Colloque PEP - 2016

THE NATIONAL BURDEN IN FRANCE OF HOSPITAL CARE FOR PATIENTS WITH HEPATIC ENCEPHALOPATHY: DATA FROM THE FRENCH NATIONAL HOSPITAL DATABASE (PMSI)
cécile BLEIN/ Camlle AMAZ
UEGW - 2016

Utilisation des données françaises du PMSI pour évaluer l’impact en santé publique des hospitalisations pour encéphalopathie hépatique
cécile BLEIN/ Camlle AMAZ
JFHOD2016 - 2016

AN ASSESSMENT OF ANNUAL COSTS OF PATIENTS HOSPITALIZED FOR SPINAL TUMORS IN FRANCE: ANALYSIS USING THE PMSI DATABASE
Lucie de Léotoing / Charlène Tournier / Alexandre Vainchtock
ISPOR - 2015

Cancer – épidémiologie : Délais d’accès à la chimiothérapie adjuvante après une chirurgie curative dans le cancer du poumon (étude TERRITOIRE)
Cécile BLEIN / Alexandre VAINCHTOCK / Benoit SAITTA
CPLF (congrès de Pneumologie de Langue Française) - 2015

The cost of thromboembolic events in hospitalized patients : a stdy on four major cancer localizations
Alexandre vainchtock
ESMO - 2015

Thromboembolic Events in Hospitalized Cancer Patients: Impact on stay duration and cost for four majour cancer localizations
cécile BLEIN
ASCO palitaive care - 2015

OF MELANOMA IN FRANCE IN THE ADVANCED/METASTATIC SETTING: THE MELISSA STUDY (MELANOMA IN HOSPITAL COSTS ASSESSMENT)
Lucie de LEOTOING/ Camille Amaz / Alexandre Vainchtock
ESMO - 2015

Accès aux médicaments de la « liste en sus » chez les patients atteints de cancer du poumon métastatiques (étude TERRITOIRE)
Cécile Blein /Alexandre Vainchtock/benoit saitta
CPLF (congrès de Pneumologie de Langue Française) - 2015

Disparités régionales et socio-économiques dans le cancer du poumon (étude TERRITOIRE)
Cécile Blein /Alexandre Vainchtock/soline leblanc
CPLF (congrès de Pneumologie de Langue Française) - 2015

en attente
Lucie de LEOTOING/ Alexandre Vainchtock
ISPOR 2015 - 2015

MODELING OF CLINICAL PATHWAYS IN THE IMPLANTATION OF CARDIOVERTER DEFIBRILLATORS FROM 2006 TO 2013 USING THE FRENCH HOSPITAL P.M.S.I. DATABASE
Prodel M, Jouaneton B, Lamarsalle, Vainchtock
ISPOR 2015 - 2015

"Modelisation du parcours patient dans l’implantation de Defibrilateurs cardiaques de 2006 a 2013 a partir du pmsi "
Prodel M.a, Jouaneton B.a, Lamarsalle La
8 èmes JGS Nimes 2015 - 2015

Impact du recueil de l’indicateur de mortinatalite sur le codage des naissances au sein du pmsi entre les annees 2011 et 2013
Blein C, Chaise G, Lamarsalle L, Vainchtock A
8 èmes JGS Nimes 2015 - 2015

Incidence and costs of thromboembolic events in cancer patients: a study on four major cancer localizations
Alexandre VAINCHTOCK
ASCO - 2015

Incidence and costs of thromboembolic events in cancer patients: a study on four major cancer localizations
Alexandre VAINCHTOCK
ASCO - 2015

Le syndrome de grêle court (SGC) en France chez l’adulte. Données épidémiologiques à partir du PMSI
Cécile BLEIN
JFHOD 2015 - 2015

Features And Causes Of Death Of Patients With Atrial Fibrillation Seen In French Hospitals In 2012
Gwendoline CHAIZE/Alexandre VAINCHTOCK
AHA Scientific Sessions - 2014

The cost of thromboembolic events in hospitalized patients with colon or lung cancer in France
Alexandre VAINCHTOCK
ASH - 2014

VTE-related hospital costs for patients with breast or prostate cancer
Alexandre VAINCHTOCK
MASCC - 2014

Thromboembolic Events in Breast and Prostate Cancer Patients hospitalized in 2011 and 2012: incidence and costs
Alexandre VAINCHTOCK
ESMO - 2014

Thromboembolic Events in Breast and Prostate Cancer Patients hospitalized in 2011 and 2012: incidence and costs
Alexandre VAINCHTOCK
ASCO PAL - 2014

The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France
Alexandre VAINCHTOCK
ASCO - 2014

Le fardeau des hospitalisations liées à l’hépatite C chronique en France :Evolution entre 2009 et 2012
Lucie de LEOTOING
75èmes Journées Scientifiques de l’AFEF - 2014

Prise en charge hospitalière de la leucémie aigüe lymphoblastique (LAL) en 2012 : données du Programme de Médicalisation des Systèmes d’Information (PMSI)
Remerciement HEVA
Congrès annuel de la Société Française d’Hématologie - 2014

Prise en charge hospitalière du purpura thrombopéniqueimmunologique (PTI) chez l’adulte en France en 2012 : données du Programme de Médicalisation des Systèmes d’Information (PMSI)
Remerciement HEVA
Congrès annuel de la Société Française d’Hématologie - 2014

Burden of cardiovascular complications in patients with atrial fibrillation in France
Gwendoline CHAIZE/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Burden of hospitalizations related to chronic hepatitis C in France: evolution between 2009 and 2012
Lucie de Leotoing/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Hospital cost of thromboembolic events in breast or prostate cancer patients
Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Mean annual cost of patients hospitalized for chronic hepatitis C in France: the HEPC-LONE study
Lucie de Leotoing/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Hospital Costs of Thrombocytopenia Related to Hepatitis C Virus Infection : Analysis of the French Hospital Discharge Database
Alexandre VAINCHTOCK
48th Annual Meeting of the European Association for the Study of the Liver - 2013

Analysis of public and private hospital databases (PMSI) 2010 / 2011 to estimate the frequency and associated costs for febrile neutropenia in France
Alexandre VAINCHTOCK
ISPOR 16th Annual European Congress - 2013

Analysis of re-hospitalisations for stroke and transient ischemia recurrence and associated costs in the burgundy region in France
Rémi MARTY/Baptiste JOUANETON/Stéphane ROZE
ISPOR 16th Annual European Congress - 2013

Zona à l'hôpital en France : Quels patients ? Quel type d'hospitalisation ? Quel coût ?
Alexandre VAINCHTOCK/ Cécile BLEIN
Journées Annuelles de la Société Française de Gériatrie et Gérontologie JASFGG 2013 - 2013

Evaluation of the herpes zoster impact as comorbidity factor in 5 pathologies french hospital care among adults aged 50 and older
Cécile BLEIN/Alexandre VAINCHTOCK
ISPOR 16th Annual European Congress - 2013

Analysis of hospital-specific drg payments for stroke according to united states medicare perspective
Cécile BLEIN/Rémi MARTY/Stéphane ROZE
ISPOR 15th Annual European Congress - 2012

2-year incidence of stroke and hemorrhages hospitalizations and costs within atrial fibrillation patients in France
Gwendoline CHAIZE/Alexandre VAINCHTOCK
ISPOR 15th Annual European Congress - 2012

4-year incidence and costs of hospitalized complications within kidney transplant patients in France
Alexandre VAINCHTOCK/Gwendoline CHAIZE
ISPOR 15th Annual European Congress - 2012

Preventing alzheimer disease: is there a place for cost-effective interventions? dynamic modeling applied to a pan european analysis
Stephane ROZE/Alexandre VAINCHTOCK/ Remi MARTY
ISPOR 15th Annual European Congress - 2012

Hospital costs related to hepatitis C virus infection: first analysis of the French hospital national data base
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ISPOR 14th Annual European Congress - 2011

Hospitalisation costs for HPV-related cancers in males and females in France
Remerciement HEVA
ISPOR 13th Annual European Congress - 2010

Cost of management of breast cancer with brain metastases using French hospital patient chaining system
Alexandre VAINCHTOCK
ISPOR 13th Annual European Congress - 2010

Economic Burden of Osteoporosis in Women; Data From the 2008 French Hospital Database
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ASBMR 32 Annual meeting - 2010

Economic burden of osteoporosis-related fracture hospitalizations in France
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ISPOR 13th Annual European Congress - 2010

Analysis of hospital events meaning iatrogenicity, anhemia
Alexandre VAINCHTOCK/Ludovic LAMARSALLE
ISPOR 12th Annual European Congress - 2009

Budget impact model for determining the hospital costs of introducing prasugrel for the long term treatment of acute coronary syndrome treated by percutaneous coronary intervention in France
Alexandre VAINCHTOCK
ISPOR 12th Annual European Congress - 2009

Hospitalisations for head and neck cancers in France
Alexandre VAINCHTOCK
ISPOR 12th Annual European Congress - 2009

Vulvar and vaginal diseases in France: evaluation from hospital stays
Alexandre VAINCHTOCK
Eurogin Conference - 2008

Hospitalisation and management costs of patients with penile cancer in France
Alexandre VAINCHTOCK
16th United European Gastroenterology Week - 2008

Hospitalisation and management costs of patients with anal cancer in France
Alexandre VAINCHTOCK
16th United European Gastroenterology Week - 2008

Managament costs of patients with vulvar and vaginal cancer in France
Alexandre VAINCHTOCK
ISPOR 11th Annual European Congress  - 2008

Use of an administrative database to estimate the number of hospital admissions for immune thrombocytopenic purpura and its economic burden in France
Alexandre VAINCHTOCK
ISPOR 11th Annual European Congress  - 2008

Use of an administrative database to estimate the economic burden of febrile neutropenia
Alexandre VAINCHTOCK
ISPOR Tenth Annual European Congress - 2007

Contact us